Golub Capital BDC, Inc. (GBDC) Earnings Call Transcript & Summary

May 11, 2022

NASDAQ US Financials Capital Markets earnings 45 min

Earnings Call Speaker Segments

David Golub

executive
#1

Appreciate that, Jon. Good day, everyone, and thank you for being with us. Alongside me are Chris Ericson, who serves as our Chief Financial Officer; Greg Robbins, Senior Managing Director; plus Jon Simmons, a Managing Director at Golub Capital. We released the earnings press release yesterday covering the quarter that closed on March 31st, and an earnings presentation is now available on our website. Throughout today's call, we will be referencing that presentation. If GBDC is new to you, our investment approach centers on extending first-lien senior secured loans to healthy, resilient middle-market businesses that have the backing of strong, partnership-oriented private equity sponsors. The key takeaway for this quarter: GBDC delivered yet another strong and consistent performance, and that happened even with a very difficult macro environment, which featured climbing interest rates, ongoing supply chain problems, the war between Russia and Ukraine, and a major selloff across equity and fixed income markets. For the quarter ending March 31, adjusted NII per share prior to the capital gain incentive fee accrual came in at $0.30, adjusted EPS reached $0.39, and ending NAV rose to $15.35 per share from $15.26 per share. GBDC paid a quarterly distribution of $0.30 per share during that period; in our view, these results demonstrate how resilient our strategy is, and we will discuss that further as today's call continues. At this point, I'll turn things over to Gregory, Jon and Chris to go deeper into GBDC's quarterly performance. Once they're done, I will offer some closing remarks, share our outlook, and then take your questions. Gregory, the floor is yours.

Greg Robbins

executive
#2

Thanks, David. I'll kick things off on slide six, where we lay out two main themes behind GBDC's success this quarter. Theme number one: strong portfolio performance. Please take a look at the Golub Capital Middle Market Report, or GCMMR, dated March 31st, which came out a few weeks back. Median earnings growth came in at just under 10% for January and February, comparing 2021 with the same months in 2022. Even though GDP declined 1.4% on an annualized basis in Q1, adjusted for inflation, Golub Capital's portfolio companies kept delivering solid results. That shows up not just in strong credit results — we'll dig into those numbers later in this presentation — but also in the quarter's second key theme: net portfolio growth. Origination at Golub Capital beat what we had anticipated. We figured the first calendar quarter would be sluggish. It usually is, and we figured dealmakers would need to catch their breath following a really busy 2021. Partly, we got that right. M&A wasn't especially strong. That said, Golub Capital's origination in calendar Q1 came in above our expectations, largely because our portfolio companies were playing offense. They were closing add-on acquisitions and executing growth programs, which opened up new investment opportunities for Golub Capital. Origination among existing borrowers — what we refer to as incumbency — made up more than 70% of all originations across the platform this quarter. In calendar Q1, GBDC's net portfolio growth also got a tailwind from unusually low repayment. Now turning to Slide 7. This slide gives you a bridge from GBDC's $15.26 NAV per share as of 12/31 to its higher $15.35 NAV per share as of 3/31. Let's go through that bridge. Adjusted NII per share came to $0.27, dividends per share paid during the quarter were $0.30, and adjusted net realized and unrealized gains per share were $0.12. Now let's take a closer look at our results for the quarter. To do that, I'll hand the call over to Jon Simmons, who will walk you through the results in more detail. Jon?

Jon Simmons

executive
#3

Thank you, Gregory. On Slide 9, you'll find a summary of how we performed this quarter and across the recent quarters. Gregory has already gone over what happened in the March quarter. This slide additionally highlights GBDC's steady, strong adjusted NII, adjusted NII prior to the capital gains incentive fee accrual, adjusted net realized and unrealized gains, EPS, and distributions throughout the last several quarters. Let's move on to Slide 10. As Gregory mentioned, net originations came in above what we had anticipated for this quarter. New investment commitments reached $323.2 million. Once we account for repayments on investments totaling $122.2 million, along with unrealized appreciation and other portfolio activity, total investments at fair value rose 5.4%, or $279.4 million, during the quarter. Additionally, at March 31, we held $40.6 million in undrawn revolver commitments and $203.2 million in undrawn commitments on delayed draw term loans. Both of these unfunded commitment figures are fairly modest relative to GBDC's robust balance sheet and liquidity position. Lastly, as the bottom of the table indicates, the weighted average rate and the spread over LIBOR on new investments were both unchanged quarter-over-quarter. Slide 11 demonstrates that GBDC's overall portfolio mix by investment type stayed the same quarter-over-quarter, with one-stop loans still making up roughly 80% of the portfolio at fair value. Slide 12 shows that GBDC's portfolio continued to be highly diversified by obligor, with an average investment size below 40 basis points. At March 31, 94% of our investment portfolio consisted of first lien senior secured floating rate loans and was defensively positioned in industries we consider to be resilient. Now to Slide 13. This graph provides a summary of portfolio yields and net investment spreads for the quarter. Let's look first at the light blue line. That line shows the income yield, meaning the actual amount earned on our investments, including interest and fee income, but not including the amortization of upfront origination fees and purchase price premium. The income yield fell by 20 basis points to 6.9% for the quarter ended March 31. The investment income yield, or the dark blue line, which does include the amortization of fees and discounts, dropped by 40 basis points to 7.3% for the quarter, driven by an unusually low level of repayments. Repayments can be cyclical, and we don't anticipate this low level of repayments continuing in future periods. Our weighted average cost of debt, or the aqua blue line, rose by 10 basis points to 2.8%. Our net investment spread, or the green line, which represents the difference between the investment income yield and the weighted average cost of debt, fell by 50 basis points to 4.5%. Both LIBOR and SOFR base rates rose during the quarter, which drove up interest expense but didn't meaningfully boost interest income, since most of our loans have 1% base rate floors. After the quarter ended, we've continued to see base rates rise, and these increases are expected to add to interest income and earnings in future periods, all else being equal. Having said that, I'm going to pass things along to Chris, who will pick up the conversation about GBDC's results for the quarter. Chris?

Chris Ericson

executive
#4

Thanks, Jon. Moving on to the following two slides, non-accrual investments represented 1.5% and 1.1% of total debt investments at cost and fair value, respectively, as of March 31, driven by a rise in non-accrual investments from five to seven. Broadly speaking, fundamental credit quality is still solid, with more than 90% of portfolio investments carrying an internal performance rating of four or higher as of March 31. Keep in mind that independent valuation firms assess no less than 25% of our investments every quarter. On slides 16 and 17, you'll find additional detail regarding our balance sheet and income statement as of and for the three months ended March 31, 2022. Now to slide 18. The top graph recaps our quarterly returns on equity for the last five years, while the bottom graph recaps our regular quarterly distributions along with our special distributions during that same period. On to slide 19. This graph shows our lengthy track record of robust shareholder returns since our IPO. As you can see, investors who participated in GBDC's 2010 IPO have realized a 10% IRR on NAV since inception. Slide 20 recaps our liquidity and investment capacity as of March 31, which is still robust, with more than $950 million of capital available via cash, restricted cash and availability under our various credit facilities. Slide 21 recaps the terms of our debt facilities as of March 31. Slide 22 recaps our recent distributions to stockholders. Most recently, our Board declared a quarterly distribution of $0.30 per share payable on June 29, 2022 to stockholders of record as of June 3, 2022. With that, I'll hand things over to David for some closing remarks.

David Golub

executive
#5

Thank you, Chris. In closing, GBDC delivered a robust quarter. The companies in our portfolio kept performing nicely; gains both realized and unrealized came in strong; and fresh commitments, paired with few repayments, produced solid net growth in the portfolio. Before I take questions, let me spend a moment on how we see things looking ahead. Over the past few quarters I've described us as cautiously optimistic regarding what lies ahead for Golub Capital and GBDC; that remains true, though the cautious portion of that view is growing. Before explaining what makes us cautious, though, I'd like to walk through and call out four points that give us optimism. The first is how strong GBDC's portfolio is. We've discussed this throughout today's call. Even with the negative GDP figure reported for the first quarter recently, and even with the drop in stock market prices, the companies we hold keep posting strong growth versus a year earlier in revenue as well as EBITDA. Do I think the pace seen in 2021 will slow? Without a doubt. Even so, growth remains robust, and the number of companies displaying signs of credit stress stays very small. Optimism point number two is the strength and flexibility of GBDC's balance sheet. As interest rates climb, we sit in a good position, with roughly half of GBDC's debt funding coming through low-cost fixed rate unsecured debt. In our view, GBDC stands to gain once rates rise past the LIBOR or SOFR floors on GBDC's assets. That's already beginning to show up, since floors are usually 1%. Optimism point number three is the momentum visible across the private equity ecosystem. A lot of people forecast that the private equity ecosystem's overall size will double over the next three to five years; for us and for other top private debt participants, that translates into a growing opportunity set. And last, a shift in market share is taking place. Inside the sponsor finance industry, business is moving toward the market-leading players. Our read is that the private equity winners are concentrating their business with lenders possessing scale, product breadth, and expertise, and who are, more broadly, strategically valuable partners. If those four factors driving optimism sound familiar, they should. I've gone over these trends across the last several quarters, but clear skies aren't guaranteed. So let's turn to how three sources of uncertainty temper our optimism. Begin with COVID. It's meant to be finished by now, yet it isn't. As a matter of fact, leading virologists now tell us that although more than 60% of Americans have had COVID, and more than 75% of youth, not only are we not at herd immunity, we might never reach herd immunity. Instead, we'll probably have to learn to live alongside COVID, and it might not be only COVID. Global pandemics might become part of the new norm. Number two is inflation and higher interest rates. Here's the good news. The good news is that everyone now agrees inflation is a problem. To me, this matters a lot, since recognizing that something is a problem has to come before you can fix it. For quite a long stretch, many economists and Fed officials believed inflation was transitory and didn't require action; that part is encouraging. The discouraging part is that bringing inflation under control is difficult. So although all of us as investors ought to prepare for many possible outcomes, what we consider most likely is that inflation will stick around for some time, that elevated rates will persist for some time, and that every one of us will have to adapt to both. Ukraine is the third place uncertainty comes from. We've all seen coverage describing this as a standoff between superpowers in the nuclear era, along with risks of escalation. That is all accurate. My focus here is on how much this war has produced a worldwide reset of the international monetary and trading system. Essentially, the West has taken steps through limits on Russian foreign currency movements and duties on Russian goods that amount to basic alterations to the lively economic order and to international monetary and trading norms that have existed since World War II. I believe it will require time for companies, governments, and investors to grasp and adapt to every second and third order consequence of these new norms. In my judgment, investors would be wise to get ready for an extended period of heightened market volatility while we all watch how those second and third order consequences unfold. From the standpoint of GBDC shareholders, the encouraging part is that our niche in Sponsor Finance is fairly well shielded from these three places uncertainty comes from. Together with our sponsors and our borrowers, we managed to handle COVID risk. The loans we hold carry floating rates, so they move with changes in interest rates. Most of our borrowers are American companies selling to American customers. As a result, what happens to the international trade system, the international monetary system, and unstable commodity markets affects them less. So COVID, interest rates, and the war do affect us, but I believe our position is strong for producing continued stable results. With that, operator, please open the line for questions.

Finian O'Shea

analyst
#6

Hi, everybody. Good afternoon. David, I'd like to pose something about recurring revenue loans. For a number of years, you've been a pioneer in that segment. And the way we understand it, these businesses generate less cash on an ongoing basis, since they're putting that money into marketing, research, and so on. Yet intuitively, that would leave them more vulnerable to higher interest rates on what they owe, correct? They might trim costs, but doing so wouldn't necessarily serve them well. Fin, with everything you've seen in this space over the years, how confident are you in the financial strength of this category — specifically, can it absorb base rates climbing to 1%, 2%, maybe even 3% before long?

David Golub

executive
#7

That's a terrific question. To give everyone the proper grounding on what this category is and what prompted Fin's question, let me back up a bit; the subject here is recurring revenue loans. The borrowers are companies, typically software firms, that have deliberately run elevated SG&A or R&D spending as a share of their top line, allowing them to grow quickly even if that means sacrificing profitability; typically, these loans also come with a lower LTV. But if you look at standard credit measures, like debt-to-EBITDA, the picture isn't so great. We've spent about 8 years in the business of lending against recurring revenue. As one of the first movers, it's been a really rewarding journey for us; our results have been quite strong, and we've seen very few losses on loans. In this category, I think we've delivered excellent outcomes for our investors. That said, my view is that the larger players in recurring revenue today are considerably less appealing to a lender than they used to be. Part of the reason is the point you brought up, Fin: when interest rates go up, these businesses face higher cash burn, and they have to find a way to deal with that. That's not being covered by the cash the business generates. Instead, it's handled either by fresh money coming into the picture or by funds already held on the balance sheet. Which means, logically, when rates climb, the burden on those companies grows, since the money needed to service interest must originate somewhere. Competition is the other factor behind why I view these loans as having lost some appeal. Eight years back, we were early movers here, and at that time spreads stood wider, leverage measured against recurring revenue sat at lower multiples, and covenants were stricter. This shift is just a typical aspect of what happens as you build out a fairly new segment. Over the past year or so in particular, those have all gotten less appealing from a lender's standpoint. So because of that, we've shifted our attention to different areas. If you look at our originations, as Jon mentioned in his opening remarks, about 70% of the loans extended through our platform in calendar Q1 involved incumbencies — that is, companies that were already borrowing from us. With the unpredictable environment I mentioned before, we're placing heavy focus at the moment on making sure our lending reaches businesses positioned to handle rising rates, inflation, and the uncertainties we're facing. The one category we favor above all is the businesses we understand most deeply, which means the companies already in our portfolio.

Finian O'Shea

analyst
#8

That's useful. Building on a few things you said about competition and origination — I realize the first quarter tends to run seasonally weak for you on origination, but how are things shaping up at this point? The market has gotten more volatile, so demand could be somewhat softer, and yet there's still plenty of money flowing into direct lending products, as all of us can observe. What's your view — or what do you anticipate for top line growth, or at minimum origination? Is the pipeline filling up the way it typically would at this stage of the year?

David Golub

executive
#9

So once more, I'll look backward before I look forward. Take Q1 — as you noted, Q1s are usually seasonally soft. And like Greg mentioned in our prepared remarks, we figured Q1 would be exceptionally low given the pull forward into 2021; our thinking was that a large number of sellers moved their sales, their company sales, into 2021, so they could steer clear of the possibility of higher capital gains tax rates, and that this would affect the first quarter of 2022, perhaps even beyond that within 2022. We got that partly right; still, looking at origination across our whole platform in Q1, it came in roughly 30% higher year-over-year. As I said, it leaned very heavily toward existing borrowers. That said, on the whole, the attractiveness of the opportunities we encountered in Q1 was a pleasant surprise. Moving into Q2, we're noticing a bit of acceleration. Is the pace as quick as 2021? No, I wouldn't anticipate that. I believe 2021 will turn out to be an outlier for a while. Certain special factors drove 2021 to be as active as it was — emerging from COVID and the pull-forward effect of the expected tax law changes I just referenced; even so, I think Q2 will be a pretty strong quarter for us when it comes to origination. I do believe we're beginning to feel some of the consequences you'd anticipate from the market downdraft. New deal activity is sliding to the right somewhat. And that makes sense. That's typical in this sort of environment. Even with that, I expect calendar Q2 to be a solid origination quarter for us.

Finian O'Shea

analyst
#10

Got it — that's useful. And I suppose there's one more thing, if that's alright. Could you discuss credits and how the outlook shapes up given that the Fed is moving in the opposite direction — the reverse, really, of the 2020 COVID period, when monetary and fiscal help came from the government on every side, plus private equity backing for companies, since all of that was meant to be temporary and indeed turned out that way, even though, as you noted, COVID remains an issue; yet this moment feels unlike that one, with the Fed tackling inflation and looking quite serious about it, so financial conditions are tightening as a result. What's your view on the outlook for sponsor middle market credit, along with loss and default rates for the asset class overall?

David Golub

executive
#11

Credit conditions are set to become harder. Take a look at sponsor finance, sure, but also liquid credit markets more broadly: during the first 4 months of 2022, the S&P LCD index recorded no defaults at all. Zero is the floor, so improvement isn't possible — things will deteriorate. Which elements will drive conditions in the worst direction? Well, you named one: interest rates moving higher. Then there's a second: certain companies will end up on the unfavorable side of the inflation curve, and inflation will hit their costs, yet they won't possess enough pricing power to lift prices sufficiently. A third problem, in my view, is supply disruptions, which will affect certain companies. The situation in Shanghai at present is quite frightening for a lot of businesses depending on technology inputs. So across the system, I believe we'll witness additional credit stress. Regarding our portfolio, I feel fairly confident. As I said during my opening remarks, inflation is something we've expected for 2 years. We've considered ways to arrange the portfolio so it can show genuine resiliency when inflation and rising interest rates are in play. Russia and Ukraine are not places where we hold exposure. Our exposure to China is comparatively small. So Fin, I believe we're positioned well to keep up our track record of beating the market by a meaningful margin; still, it seems reasonable to anticipate that credit markets will become harder in the period ahead.

Finian O'Shea

analyst
#12

All right. That covers everything from my side. Many thanks.

Ryan Lynch

analyst
#13

Good afternoon, everyone. I'd like to discuss that Golub Middle Market capital report your team released. It's a really useful document and offers quite a few insights. During today's call, you mentioned that solid revenue and earnings growth is still showing up across the first two months of calendar Q1 of 2022. However, looking at the report, the total portfolio posted revenue growth of 18% and earnings growth of 9%, which could point to fairly significant margin compression across the overall portfolio; and looking at the separate subsectors, there are some outliers present too. Take industrial — up 12%, with total revenue growth and earnings, a decline of almost 2%. So although things appear quite strong right now, I'd really like to hear your thoughts on what margin trends you're observing in your portfolio. And how do you see that playing out moving forward?

David Golub

executive
#14

Glad to. But Ryan, before I address that, I feel I have to push back on something you published earlier today. You wrote that in your view we missed on NII per share. I don't share that view. It's been some time since we've had a capital gain incentive fee accrual. So let me walk everyone through how that mechanism works, since it's quite peculiar accounting; so, if like Golub Capital, you're a BDC that has performed exceptionally well on the credit side and carries net realized and unrealized gains from inception, that situation is very, very uncommon. Very few companies can claim to have that. When that's the case, the accounting rules require an as-if liquidation at quarter end. So, you presume that every one of your unrealized positions gets realized, that they're then more and you work out what the incentive fee — the capital gain incentive fee would amount to if all of that occurred; so we had roughly $0.04 of capital gain incentive fee that sits above the NII line and that's what pushed our NII lower. But this isn't a cash expense; as a matter of fact, when you figure out what's owed in cash you perform an entirely separate calculation. You examine realized gains and you examine realized and unrealized losses. And so, in fact, this is not merely a non-cash expense, it's also offset by an income item that lands below the NII line. The only way a capital gain incentive fee accrual can occur is if you have substantial net realized and unrealized gains, which naturally we had this quarter. So, I apologize for singling you out. I don't mean to single you out, but I do take issue with that portion of your analysis. I believe we had a really strong quarter that you need to look past the capital gain incentive fee accrual when examining NII. From my perspective, what would serve shareholders best is if we recorded a substantial capital gain incentive fee accrual each quarter, since that would indicate we're sitting on quite meaningful net realized and unrealized gains.

Ryan Lynch

analyst
#15

I'm with you on all of that, totally agree. We had $0.31 and the Street had $0.31. Was it not adjusted NII, or after backing out the capital gain incentive fee, $0.30 — which lands under the $0.31 consensus, or at least that's how slide 4 presents it? If I'm not overlooking anything, it came across as a miss.

David Golub

executive
#16

So what you're pointing to is $0.31 against $0.30. Fine. To me, that's just rounding. There are additional items in play too. We recorded some PIK income on preferred — on preferred instruments we hold, and that income we take below the line in realized and unrealized. Other BDCs put it above bar. Maybe I'm biased, but my view is EPS beats NII as a measure by a wide margin, though we can pick that argument back up offline. Let me return to your earlier question about how the company performed. You're completely correct that the latest Golub Capital Middle Market Index showed a growth slowdown compared with what 2021 delivered. And it flipped something we'd seen fairly consistently throughout 2021, which was profit growth actually running ahead of revenue growth. This past quarter, exactly as you framed it Ryan, revenue growth came in ahead of profit growth. Whether a single quarter hands us sufficient data to reach many solid conclusions on that, I doubt. Had that pattern persisted across a longer stretch, and had profit growth begun declining further to where, in real terms, it turns negative, then your argument that this signals, perhaps indicates, challenges ahead would strike me as more persuasive. As things stand, what I observe is revenue growth that remains very strong and profit growth that remains really quite solid. Quarter to quarter, we've always witnessed some industry-level volatility. And for me, given the supply chain problems from Q1, weaker results in industrials aren't a shock. When I look across the portfolio using various measures beyond just the middle market index — including performance ratings of 94% in Category 4 and 5, the low level of non-accruals at 1.1% of fair value, and the fact that a number of companies which historically underperformed are actually getting better — my overall read on portfolio performance is genuinely positive. Of course, all of that trails reality; at best we're examining history rather than projections, budgets, or forecasts. So we need to temper that data analysis with what we're seeing on the horizon.

Ryan Lynch

analyst
#17

Yeah, I completely agree. What I'm saying is that I believe the past has been excellent. I think the concern everyone has is what the future holds — not specifically for you, but for all of these private businesses. Another question I had was this: you guys mostly operate in the direct loan private credit markets, yet you also have a sizable broadly syndicated loan business, and those two markets overlap somewhat. I'm just curious — over the last, say, couple of weeks or the past month, how has the broadly syndicated loan market been performing, since clearly that affects the pipeline and whether people want a private solution instead of accessing those markets?

David Golub

executive
#18

Sure. Over the past month, the broadly syndicated market has been quite bumpy. A typical broadly syndicated loan, I'd say, is down roughly one point during that stretch. Amortize that across an expected life of three years, and you get spread widening of approximately 33 basis points. Looking at the new issue market, we've seen some comparable signals — it hasn't been robust, but there has been some activity. And regarding new issue, I'd say once again there are indications of a modest degree of spread widening in that market. Something else we're observing in the broadly syndicated market that I find interesting and worth monitoring is a slowdown in new CLO formation. That matters because typically over 70% of the buyers of new broadly syndicated loans are CLOs. So when new CLO formation slows, that removes some buyers from the market. Thus, I think we'll probably see some continued spread widening. I think we're seeing it in the high yield market. In the high yield market, it's more pronounced. And Ryan, I think the usual pattern is that these things happen first in liquid credit markets and then they migrate down to the private market over time; that's my expectation this time as well.

Ryan Lynch

analyst
#19

All right, that helps. Then the second thing I wanted to ask about — I mentioned earlier the worry around March. To reiterate, these issues exist across the entire private credit space, not specific to GBDC, though you're definitely feeling the effects. I'd really value your perspective, since you understand this market so well. When I look at the public markets — public equities, specifically — valuations have undergone an enormous reset. Especially among companies with robust positive cash flow that are strong secular growers. Think of names like Dolby or Salesforce, for instance. You seem to hold quite a few positions in really solid, secularly growing companies that will likely be fine on an earnings and EBITDA basis. The problem is that the repricing we saw in public equities — stocks falling 20%, 30%, 40% — even for very healthy businesses, eventually shows up in private markets too. My guess is that hasn't occurred yet. It might not occur at all, but if it did, what would the implications be? Does that worry you? Clearly these companies can still service their interest and remain strong, but at some point, you need to be repaid. So my question is, I suppose, whether you're concerned we'll witness a significant — not minor, but significant — decline in private market valuations? And what would the consequences be?

David Golub

executive
#20

Let me break that into a few separate parts, and I'll start with the opportunity angle. When public markets drop sharply, one of the earliest patterns we observe is funds going private. Private equity sponsors start scanning public companies, spotting those that are undervalued, and trying to bring them into the private equity world. That's already beginning to happen. In fact, over the past few months we've helped finance a number of such deals. I view that as a favorable development. Our equity portfolio isn't especially big — it represents roughly a couple of percent of the portfolio. That said, other BDCs hold far bigger equity stakes, and for them, shifts in equity market values could have a much bigger effect on unrealized marks. For us, I doubt it becomes a major issue. Then there's a third possible effect: it matters if we hold an underperformer. Your logic is correct. By and large, these businesses are doing quite well. When they're doing well, a 25% drop in value doesn't really matter to us as the lender. But when they're struggling, we're arguably eroding some of the critical cushion that protects us from taking a credit loss. So that's a piece of what we do — we have to constantly watch for anything underperforming, and we engage with the people who borrow from us and with our sponsors to tackle that weakness right away, so it never turns into a credit loss down the road.

Ryan Lynch

analyst
#21

Understood; that breakdown of how things are shifting is really useful; that covers everything I wanted to ask about. Thanks for the time and for talking it through.

David Golub

executive
#22

Thank you, Ryan.

Robert Dodd

analyst
#23

Hey, everyone. So, a question regarding software too — clearly, software makes up 25% of the portfolio. I've got a few things to ask here. First, I'd be interested in knowing what portion of that consists of recurring revenue as opposed to cash flowing software businesses? But the more significant issue, given that software is such a big chunk — and software is a pretty broad label — is this: within your software exposure, can you give any detail on diversification across end markets? It's not like every bit of it is software for graphic design, correct? It covers various things. So how varied is it? And should we be mindful of any concentrations in specific subsectors?

David Golub

executive
#24

Well, there are a few points I can make, and a few points that we're probably better off holding for later, and we'll see whether we can enhance our transparency next quarter. What I can tell you is this: the bulk of that software exposure isn't recurring revenue loans. Instead, it's cash flow lending to highly successful, highly resilient, mission-critical business-to-business software companies: SaaS model, extremely high recurring revenues, extremely high repeat customer counts, extremely low customer attrition, extremely high free cash flow; so that profile appeals to us. We hold a lot of these. We were the first among direct lenders to enter the technology lending space, and I believe we continue to have the biggest technology portfolio as a platform in the industry. I consider this one of our genuine areas of expertise and competitive advantages. As for end markets, they're quite diversified. If you don't mind, I'd like to treat it as a homework assignment to find a way to illustrate this in our upcoming 10-Q, so we can share that information with you. But I'm confident in the conclusion that — and the conclusion will be that — we lack meaningful concentrations by end market. And I believe that matters, since not all software companies move in unison when idiosyncratic changes hit the economy. The superior approach to examining factor risks in software lending rests on end market.

Robert Dodd

analyst
#25

Thanks for that. Assigning tasks is fine by me — it's the doing of them I'd rather skip. Turning to healthcare: that's another space you've kept your eye on for quite a while. Before COVID hit, a big chunk of it fell into what you might call discretionary spending — discretionary healthcare, that is. Then COVID came along and really threw things into disarray, since so many of those businesses had to close their doors. Things are bouncing back now, and this quarter every one of the Street names got marked up. Is there any worry, or anything significant, that the mindset of people buying healthcare has shifted from here on out — especially if inflation keeps climbing, or if the economy cools and joblessness goes up? Did the pandemic show them they're able to put these things off for a while? And if an economic problem hits down the road, does that raise the odds of bigger delays than what you assumed when you were underwriting those businesses, including the ones you looked at before COVID?

David Golub

executive
#26

That's a great question, and truthfully, we don't have the answer at this point — we'll find out as the next several quarters play out. When I consider what you're asking and think about the various subspecialties, my sense is that the response could vary depending on which subspecialty we're talking about. Take the veterinary area, where we have a lot going on. My expectation is that Fido will keep receiving whatever Fido requires. That's how the vet space has behaved during earlier economic slumps. And with pets increasingly being treated like family, I doubt that pattern will shift. We're also involved in several other sub sectors: eye care and ophthalmology, dentistry, and derm. At this point, I haven't observed anything like what you're describing — not so far, anyway. Still, I believe it's a worthwhile question. The reality is that consumers will need to adjust in some ways. Fuel costs have climbed along with grocery bills, and many shoppers, given those two rising expenses, will need to cut back in some other area.

Robert Dodd

analyst
#27

All right, that's helpful. Thanks very much.

David Golub

executive
#28

Thank you too, David. I'm grateful to everybody for spending part of your day with us and for bringing your questions. As usual, should anything else come up on your mind prior to our next quarterly conversation, don't hesitate to get in touch. We truly value having you as partners. Thanks again.

Operator

operator
#29

This concludes today's conference call. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Golub Capital BDC, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Golub Capital BDC, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Golub Capital BDC, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.